⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

HRMY News

Harmony Biosciences Holdings, Inc. Common Stock

Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M